Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

303 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CSF monoamine metabolites in old age dementias.
Parnetti L, Gaiti A, Reboldi GP, Santucci C, Mecocci P, Brunetti M, Cadini D, Senin U. Parnetti L, et al. Mol Chem Neuropathol. 1992 Feb-Apr;16(1-2):143-57. doi: 10.1007/BF03159966. Mol Chem Neuropathol. 1992. PMID: 1381590
Platelet MAO-B activity and vitamin B12 in old age dementias.
Parnetti L, Mecocci P, Reboldi GP, Santucci C, Brunetti M, Gaiti A, Cadini D, Senin U. Parnetti L, et al. Mol Chem Neuropathol. 1992 Feb-Apr;16(1-2):23-32. doi: 10.1007/BF03159958. Mol Chem Neuropathol. 1992. PMID: 1520404
Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias.
Mecocci P, Parnetti L, Reboldi GP, Santucci C, Gaiti A, Ferri C, Gernini I, Romagnoli M, Cadini D, Senin U. Mecocci P, et al. Acta Neurol Scand. 1991 Sep;84(3):210-3. doi: 10.1111/j.1600-0404.1991.tb04940.x. Acta Neurol Scand. 1991. PMID: 1950463
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test.
Parnetti L, Mecocci P, Neri C, Palazzetti D, Fiacconi M, Santucci A, Santucci C, Ballatori E, Reboldi GP, Caputo N, et al. Parnetti L, et al. Aging (Milano). 1990 Jun;2(2):173-9. doi: 10.1007/BF03323914. Aging (Milano). 1990. PMID: 2095858
Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Passeri M, Cucinotta D, Bonati PA, Iannuccelli M, Parnetti L, Senin U. Passeri M, et al. Int J Clin Pharmacol Res. 1990;10(1-2):75-9. Int J Clin Pharmacol Res. 1990. PMID: 2201659 Clinical Trial.
It has been hypothesized that acetyl-L-carnitine has a cholinomimetic action. It is for this reason that it has been used in the therapy of Alzheimer's type senile dementia impairment. ...One group of patients underwent therapy with acetyl-L-carnitine, 2 g/day for t …
It has been hypothesized that acetyl-L-carnitine has a cholinomimetic action. It is for this reason that it has been used in the ther …
Hemorheologic factors in the postacute phase of ischemic stroke.
Ciuffetti G, Mercuri M, Parnetti L, Lupattelli G, Senin U. Ciuffetti G, et al. Angiology. 1988 May;39(5):437-48. doi: 10.1177/000331978803900506. Angiology. 1988. PMID: 3377266
Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid.
Parnetti L, Ambrosoli L, Abate G, Azzini C, Balestreri R, Bartorelli L, Bordin A, Crepaldi G, Cristianini G, Cucinotta D, et al. Parnetti L, et al. Acta Neurol Scand. 1995 Aug;92(2):135-40. doi: 10.1111/j.1600-0404.1995.tb01027.x. Acta Neurol Scand. 1995. PMID: 7484061 Clinical Trial.
INTRODUCTION: Posatirelin (L-pyro-2-aminoadipyl-L-leucil-L-prolinamide) a new synthetic tripeptide with cholinergic, catecholaminergic and neurotrophic properties, was investigated in the treatment of Alzheimer's disease. ...
INTRODUCTION: Posatirelin (L-pyro-2-aminoadipyl-L-leucil-L-prolinamide) a new synthetic tripeptide with cholinergic, ca …
303 results
Jump to page
Feedback